Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
intellectual property
Pharma
Teva notches loss in inhaler patent case against Amneal
After being called out on its intellectual property last year, Teva has fallen victim to the FTC's ongoing crusade against questionable drug patents.
Fraiser Kansteiner
Jun 12, 2024 9:35am
Novartis wants to peek at Takeda records in trade secret dispute
Oct 26, 2023 4:04pm
Viatris gets US agency to review Novo semaglutide patent
Oct 5, 2023 9:10am
FibroGen slaps former employees with trade secret theft lawsuit
Dec 5, 2022 10:55am
Viatris edges closer to a potential Symbicort generic launch
Nov 10, 2022 2:03pm
Love Pharma moves to buy transdermal opioid-use disorder player
Oct 18, 2022 9:20am
